小分子尾酒DLC79通过激活Ascl1和重塑转录基因组来抑制质生成
Chuxiao Mao1,2, Zhancheng Deng1, Zhuming Chen1,3
1Key Laboratory of CNS Regeneration (Ministry of Education), Guangdong-Hongkong-Macau Institute of CNS Regeneration, Jinan University, Guangzhou 510632, China.
Cells
|January 28, 2026
概括
研究人员开发了一种小分子尾酒,将质母细胞细胞重新编程成类似神经元的细胞. 这种药理重编程方法抑制了质瘤恶性并减少了瘤生长,提供了一种新的治疗策略.
科学领域:
- 神经瘤学神经瘤学
- 药理学重编程 药理学重编程 药理学重编程
- 癌症治疗治疗 癌症治疗
背景情况:
- 质母细胞瘤 (GBM) 是一种具有侵略性的脑瘤,由于侵袭性生长和耐治疗性,预后不佳.
- 虽然存在质瘤细胞的遗传重编程,但药理重编程提供了一个更具临床可转化性的方法.
研究的目的:
- 确定一种药理方法,将人类质瘤细胞重新编程成一种不那么恶性表型.
- 为了评估这种重新编程策略的 in vitro 和 in vivo 的有效性.
主要方法:
- 由表型驱动的查确定了一个多目标小分子尾酒 (DLC79),包括DAPT,LDN193189,CHIR99021,I-BET762和Isx9.9.
- 评估了DLC79对质瘤细胞身份,转录格局和瘤特性的影响.
- 在体外测定测量了增殖,迁移,入侵和克隆性.
- 一个皮下异种移植模型评估了DLC79预处理后的瘤生长和生物发光.
主要成果:
- DLC79有效地将人类质瘤细胞重新编程成类似神经元的细胞,激活内源ASCL1并重塑转录格局.
- 神经元标记物 (MAP2,GAD67) 被上调,而质标记物被抑制.
- 在体外,DLC79治疗抑制了质瘤细胞的增殖,迁移,入侵和克隆性.
- 在体内,DLC79预处理减少了56%的瘤生物发光和47%的瘤质量.
结论:
- 使用DLC79的药理重编程是一种可行的策略,可以将恶性质瘤细胞转化为一种不太致癌,类似神经元的状态.
- 这种方法显示出显著的抗质瘤活性,这表明了质母细胞瘤的新疗法范式.
相关概念视频
Nucleosome Remodeling
11.1K
Nucleosomes are the basic units of chromatin compaction. Each nucleosome consists of the DNA bound tightly around a histone core, which makes the DNA inaccessible to DNA binding proteins such as DNA polymerase and RNA polymerase. Hence, the fundamental problem is to ensure access to DNA when appropriate, despite the compact and protective chromatin structure.
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
11.1K
Bone Remodeling
40.4K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.4K
Osteoclasts in Bone Remodeling
4.1K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.1K
Molecules and Compounds
68.6K
Atoms and Molecules
68.6K
Prokaryotic Transcriptional Activators and Repressors
25.4K
The organization of prokaryotic genes in their genome is notably different from that of eukaryotes. Prokaryotic genes are organized, such that the genes for proteins involved in the same biochemical process or function are located together in groups. This group of genes, along with their regulatory elements, are collectively known as an operon. The functional genes in an operon are transcribed together to give a single strand of mRNA known as polycistronic mRNA.
Transcription of prokaryotic...
Transcription of prokaryotic...
25.4K
Activation Energy
86.6K
Activation energy is the minimum amount of energy necessary for a chemical reaction to move forward. The higher the activation energy, the slower the rate of the reaction. However, adding heat to the reaction will increase the rate, since it causes molecules to move faster and increase the likelihood that molecules will collide. The collision and breaking of bonds represents the uphill phase of a reaction and generates the transition state. The transition state is an unstable high-energy state...
86.6K


